Type 2 Diabetes

ADA's 2019 Standards of Medical Care in Diabetes Focus on Patient-Centered Care

ADA's 2019 Standards of Medical Care in Diabetes Focus on Patient-Centered Care

By

The ADA published its 2019 Standards of Medical Care in Diabetes, an evidence-based document intended to provide clinicians, patients, and other stakeholders in the diabetes treatment landscape with up-to-date recommendations.

T2D Linked to Decline in Verbal Memory, Fluency in Older Adults

T2D Linked to Decline in Verbal Memory, Fluency in Older Adults

Type 2 diabetes is associated with declines in verbal memory and fluency among older community-dwelling adults.

Metabolic Syndrome Highly Prevalent in Patients With Plaque Psoriasis

Metabolic Syndrome Highly Prevalent in Patients With Plaque Psoriasis

By

Metabolic syndrome and psoriatic arthritis were highly prevalent comorbidities in patients with plaque psoriasis.

SGLT2 Inhibitors and Urinary Tract Infections: What's the Link?

SGLT2 Inhibitors and Urinary Tract Infections: What's the Link?

By

For this study, the authors identified randomized controlled trials (RCTs) that compared SGLT2 inhibitors with placebo, no treatment, or another antidiabetic agent and reported on UTI outcome.

Low-Risk Patients With T2D May Be Self-Testing Blood Glucose Too Often

Low-Risk Patients With T2D May Be Self-Testing Blood Glucose Too Often

By

Patients with stable type 2 diabetes may be unnecessarily self-monitoring blood glucose levels despite this practice being recognized as a low-value service.

Liraglutide significantly reduces risk for major cardiac events in elderly patients with diabetes

A significant reduction in major cardiac events among elderly patients was seen in the liraglutide treatment group.

A Risk Prediction Tool for Hip Fracture in Type 2 Diabetes

A Risk Prediction Tool for Hip Fracture in Type 2 Diabetes

By

A hip fracture risk tool for patients with type 2 diabetes performed well in predicting incident hip fractures using readily available variables.

Hypertensive Disorders in Pregnancy, Postpartum BMI Linked to T2D Risk

Hypertensive Disorders in Pregnancy, Postpartum BMI Linked to T2D Risk

By

Postpartum women with an elevated BMI score and a history of hypertensive disorders during pregnancy have an increased risk of developing type 2 diabetes.

Type 2 Diabetes Linked to Colorectal Cancer Risk in Men

Type 2 Diabetes Linked to Colorectal Cancer Risk in Men

Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only.

Normalized HbA1c Levels Facilitate Improved Neuropathy Outcomes in T2D

Normalized HbA1c Levels Facilitate Improved Neuropathy Outcomes in T2D

By

Normalized HbA1c levels facilitated improvement in neuropathy and nephropathy in type 2 diabetes of a short duration.

Serious Adverse Events Linked to SGLT2 Inhibitors

Serious Adverse Events Linked to SGLT2 Inhibitors

By

Compared with GLP-1 receptor agonists, the use of SGLT2 inhibitors is associated with an increased risk for diabetic ketoacidosis and lower limb amputation.

Impaired Glucose Metabolism May Affect Mood Stabilizer Response in Bipolar Disorder

Impaired Glucose Metabolism May Affect Mood Stabilizer Response in Bipolar Disorder

By

High blood sugar levels may put patients with bipolar disorder at risk of not responding to lithium and other mood stabilizer treatments.

Skin Autofluorescence Predicts T2D, Heart Disease, Mortality

Skin Autofluorescence Predicts T2D, Heart Disease, Mortality

Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease (CVD), and mortality in the general population.

Cost-Related Insulin Underuse in Patients With Diabetes

Cost-Related Insulin Underuse in Patients With Diabetes

About one in four patients report cost-related insulin underuse, which is associated with poor glycemic control.

Unhealthy Lifestyle and Rotating Night Shifts Put Nurses at Higher Risk for T2D

Unhealthy Lifestyle and Rotating Night Shifts Put Nurses at Higher Risk for T2D

By

Female nurses who frequently work rotating night shifts and adhere to an unhealthy lifestyle are at significantly greater risk of developing type 2 diabetes.

Endocrine Society: Policy and Practice Changes Necessary to Improve Access to Insulin

Endocrine Society: Policy and Practice Changes Necessary to Improve Access to Insulin

By

The rising cost of insulin has made it increasingly difficult for patients with diabetes to receive affordable, life-saving medication, especially patients from low-income backgrounds, patients with high deductibles, and uninsured patients.

Elevated Triglyceride Levels Affect Glycemic Control in Type 2 Diabetes

Elevated Triglyceride Levels Affect Glycemic Control in Type 2 Diabetes

By

Reducing triglyceride levels in patients with type 2 diabetes may help them attain more optimal glycemic control.

Plasma Acylcarnitines May Indicate Risk for Type 2 Diabetes

Plasma Acylcarnitines May Indicate Risk for Type 2 Diabetes

By

Among individuals at a high risk for cardiovascular disease, a panel of short- and long-chain acylcarnitines was significantly associated with the incidence of type 2 diabetes.

Sharp Increase in Projected Global Insulin Use From 2018 to 2030

Sharp Increase in Projected Global Insulin Use From 2018 to 2030

From 2018 to 2030, the insulin required to treat type 2 diabetes is expected to increase more than 20 percent.

Ezetimibe Plus Statin Therapy Reduces Ischemic Risk in Polyvascular Disease, T2D

Ezetimibe Plus Statin Therapy Reduces Ischemic Risk in Polyvascular Disease, T2D

By

The addition of ezetimibe to simvastatin reduced ischemic risk compared with placebo, with consistent relative risk reductions in patients with and without polyvascular disease.

ACC Releases Recommendations for Treatment of Patients With T2D and ASCVD

ACC Releases Recommendations for Treatment of Patients With T2D and ASCVD

By

The American College of Cardiology published an expert consensus statement regarding decision considerations for novel cardiovascular risk reduction therapies in patients with type 2 diabetes and atherosclerotic cardiovascular disease.

Noninferior CV Outcomes for Linagliptin in T2D With High CV, Renal Risk

Noninferior CV Outcomes for Linagliptin in T2D With High CV, Renal Risk

By

Linagliptin added to usual care compared with placebo added to usual care resulted in a noninferior risk for a composite cardiovascular or renal outcome over a median 2.2 years.

Exposure to Maternal Diabetes Increases Risk for ADHD in Offspring

Exposure to Maternal Diabetes Increases Risk for ADHD in Offspring

By

The 3 main types of diabetes during pregnancy were associated with offspring ADHD risk in a hierarchical order.

Direct-Acting Antiviral Therapy Reduced Risk for Incident T2D in Patients With Hepatitis C Infection

Direct-Acting Antiviral Therapy Reduced Risk for Incident T2D in Patients With Hepatitis C Infection

The study compared US administrative claims data of HCV patients with ≥12 weeks of dispensed DAA therapy (N = 17,848) to untreated HCV patients with follow-up data (N = 108,350).

Dapagliflozin Lowers Heart Failure Hospitalization Rates in High-Risk Patients With Diabetes

Dapagliflozin Lowers Heart Failure Hospitalization Rates in High-Risk Patients With Diabetes

By

Dapagliflozin was not associated with either a higher or lower rate of MACE compared with placebo in patients with type 2 diabetes who had or were at risk for atherosclerotic cardiovascular disease.

High Circulating Prolactin Concentrations May Lower Risk for Type 2 Diabetes

High Circulating Prolactin Concentrations May Lower Risk for Type 2 Diabetes

By

High circulating total prolactin concentrations may be linked with a lower risk for type 2 diabetes in women.

ADA Issues Position Statement on Comprehensive Care for Pediatric T2D

ADA Issues Position Statement on Comprehensive Care for Pediatric T2D

By

The American Diabetes Association issued a position statement outlining the recognition, management, and prevention of T2D in the pediatric population.

Peer Support Reduces Hospitalizations in People With Diabetes and Depression

Peer Support Reduces Hospitalizations in People With Diabetes and Depression

By

Patients with diabetes and depressive symptoms who received community-based peer support for diabetes management reported less frequent acute care visits and hospitalizations than patients with diabetes without depressive symptoms.

Empagliflozin Effectively Reduces Risk for Heart Failure Hospitalization in T2D

Empagliflozin Effectively Reduces Risk for Heart Failure Hospitalization in T2D

By

Approximately 50% of deaths in people with type 2 diabetes worldwide, and approximately two-thirds of deaths in people with type 2 diabetes in the US are caused by cardiovascular disease.

Pathogenesis of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass in T2D

Pathogenesis of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass in T2D

By

Postprandial hypoglycemia may occur after Roux-en-Y gastric bypass in patients with type 2 diabetes, independent from diabetes remission.

Sign Up for Free e-Newsletters



CME Focus